SMALL CAP MOVERS: Woodford contagion reaches AIM as several 会社/堅いs 支援するd by 基金 経営者/支配人 see hefty 株 price slides

The big news in the markets this week has been the 落ちる from grace of superstar 在庫/株 picker Neil Woodford, who on Monday said he had 一時停止するd 貿易(する)ing in his Woodford 公正,普通株主権 Income 基金 for at least 28 days after a slew of 投資家s started to pull their cash.

There has also been collateral 損失 in the junior market, with several AIM-名簿(に載せる)/表(にあげる)d 会社/堅いs 支援するd by Woodford 苦しむing hefty 株 price slides in the week.

These 含む pharma 会社/堅い Circassia, which dropped 9.3 per cent to 20p in the week, 同様に as mattress 製造者 Eve Sleep, 負かす/撃墜する 9.5 per cent at 5.9p, and lorry group Eddie Stobart, which 低迷d 9.7 per cent to 74.5p.

Woodford was a 重要な 株主 in each of these 会社/堅いs, with his 基金s 持つ/拘留するing 火刑/賭けるs of 27.8 per cent, 46.8 per cent, and 25 per cent それぞれ.

Bad night sleep: Mattress maker Eve Sle
ep, backed by Woodford, has seen shares fall by 10%

Bad night sleep: Mattress 製造者 Eve Sleep, 支援するd by Woodford, has seen 株 落ちる by 10%

どこかよそで during the week, 製薬の 会社/堅い Motif Bio lost nearly two thirds of its value, 急落(する),激減(する)ing 60.3 per cent to 3.5p after the US 麻薬 regulator encouraged the company to carry out another 裁判,公判 on its iclaprim 抗生物質 to assuage 関心s over possible 肝臓 有毒性.

In an update on Thursday the 会社/堅い said that it had requested a 会合 with the Food & 麻薬 行政 to discuss the design of a fresh 臨床の evaluation, 含むing the appropriate 患者 全住民.

The company has already 完全にするd a 段階 III 裁判,公判 for iclaprim, which is 存在 designed to 扱う/治療する 激烈な/緊急の bacterial 肌 and 肌 structure 感染s.

While another 臨床の 裁判,公判 is ありそうもない to 原因(となる) 問題/発行するs, Motif’s 投資家s may have been spooked by the prospect of an 公正,普通株主権 raise as the company looks for ways to 基金 itself past September.

投資家s were also 評価するing the 業績/成果 of Scapa after the adhesive 製品s group said it was 査定する/(税金などを)課すing the profitability 関わりあい/含蓄s from the termination of a 供給(する) 協定 with colostomy 捕らえる、獲得する 製造者 ConvaTec, with the 株 衝突,墜落ing 45 per cent to 162.6p in 返答.

Surgical 革新s Group got a scalping after a Brexit-奮起させるd 利益(をあげる) 警告 sent its 株 急落(する),激減(する)ing 33 per cent to 2.8p.

Pharmaceutical firm Motif Bio lost nearly two thirds of its value this week

製薬の 会社/堅い Motif Bio lost nearly two thirds of its value this week

一方/合間, levelling 機械/機構 specialist Somero was underwater, with the 株 沈むing 22.7 per cent to 280p after 記録,記録的な/記録する 降雨 across the US in the first part of 2019 鈍らせるd its 業績/成果, resulting in an 収入s 警告 for the 十分な year.

鉱夫 Ironveld was looking distinctly rusty after 宙返り/暴落するing 33 per cent to 1p on the 支援する of news that discussions with a 可能性のある 商業の off-take partner for its 事業/計画(する) at the Bushveld コンビナート/複合体 in South Africa had 崩壊(する)d.

The AIM All-株 was 負かす/撃墜する 2.4 per cent at 937.3 during the week while the FTSE 100 was up 2.1 per cent at 7,312.8.

In the risers, gold explorer KEFI Minerals 発射 up 37 per cent to 2p in the week after the 国家の Bank of Ethiopia 認可するd a 財政/金融ing 一括 for the company’s Tulu Kapi 事業/計画(する) in the west of the country.

集まり spectrometer 製造者 Microsaic spun 24.5 per cent higher to 1.7p after 署名/調印するing a 配当 協定 with South Korean 生命科学 and analytical 器具/備品 会社/堅い CM Corp.

Renalytix AI climbed 26.2 per cent to 255p after some 肯定的な findings from a 腎臓 移植(する) 熟考する/考慮する which showed that the company's FractalDx 大臣の地位 科学(工学)技術 could 正確に 予報する 早期に 激烈な/緊急の 腎臓 拒絶 in 移植(する) 患者s.

The data also 示唆するd that FractalDx could be used to mitigate 有毒な 味方する 影響s and 損失 to 移植(する)d 腎臓’s from immunosuppression therapy.

どこかよそで, 株 in 支払う/賃金-TV group Amino were given a 上げる jumping 14.5 per cent to 106.5p after a 井戸/弁護士席-received 貿易(する)ing update that said it was making good 進歩 with a 変形 計画(する).

Housebuilder Inland Homes rose 9.3 per cent to 62p に引き続いて news that 地元の 当局 had passed a 決意/決議 to 認める planning 許可 for its 旗艦 事業/計画(する) in Beaconsfield, Buckinghamshire.

There was also some sparkle from Jubilee Metals, which 殺到するd 16.8 per cent to 3.3p after the platinum 鉱夫 laid out 計画(する)s to 増加する 生産/産物 capacity at its 操作/手術s in South Africa.

The comments below have not been 穏健なd.

The 見解(をとる)s 表明するd in the contents above are those of our 使用者s and do not やむを得ず 反映する the 見解(をとる)s of MailOnline.

We are no longer 受託するing comments on this article.